| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B | $6.9B | $7.0B | $6.6B | $4.4B | $6.3B | $6.5B | $6.4B |
| Cost of Revenue | $3.9B | $4.0B | $4.0B | $3.7B | $3.1B | $4.2B | $4.3B | $4.2B |
| Gross Profit | $2.6B | $2.7B | $2.9B | $2.7B | $1.2B | $0.6B | $0.6B | $0.6B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.7B | $1.7B | $1.7B | $1.5B | $1.2B | $1.7B | $1.7B | $1.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.7B | $0.9B | $0.9B | $-0.1B | $0.1B | $0.1B | $0.2B |
| EPS (Basic) | $36.82 | $44.73 | $50.81 | $41.88 | $-3.16 | $4.38 | $6.23 | $7.51 |
| EPS (Diluted) | $36.82 | $44.73 | $50.81 | $41.88 | $-3.16 | $2.75 | $3.22 | $5.55 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.5B | $3.4B | $3.3B | $3.2B | $3.1B | $3.4B | $3.4B | $3.7B |
| Current Assets | $2.4B | $2.2B | $2.1B | $1.9B | $1.7B | $1.8B | $1.8B | $1.7B |
| Cash & Equivalents | $0.7B | $0.8B | $0.7B | $0.7B | $0.4B | $0.3B | $0.1B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.8B | $0.8B | $0.9B | $1.0B | $0.8B | $0.9B | $0.9B | $1.0B |
| Stockholders' Equity | $1.8B | $1.7B | $1.6B | $1.5B | $1.4B | $1.6B | $1.7B | $1.7B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.9B | $0.9B | $1.3B | $0.3B | $0.4B | — | — |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.2B | $-0.1B | $-0.0B | $-0.1B | — | — |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.5B | $-0.6B | $-0.8B | $-0.9B | $-0.1B | $-0.1B | — | — |